KEQU KEWAUNEE SCIENTIFIC CORP /DE/

$38.06 +0.77%

Healthcare · Laboratory Apparatus & Furniture

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) is a healthcare company in the Laboratory Apparatus & Furniture industry, with a market capitalization of $109 million. Shares last traded at $38.06, 36.6% below their 52-week high. Over the past year the stock is up 18.0%. KEQU trades at a price-to-earnings ratio of 9.57, below the Healthcare median of 25.98. Net profit margin is 4.7%, above the peer median of 0.0%. Revenue grew 18.0% year over year. The shares yield 1.9% in dividends.

Market Cap

$109M

Shares Out

2.9M

EPS (TTM)

$7.19

P/E Ratio

5.29

P/S Ratio

0.45

P/B Ratio

1.54

Dividend / Share

$0.74

Dividend Yield

1.94%

52-Week High

$60.00

52-Week Low

$32.81

Volume

Avg Vol (3m)

87.556

Performance

+3.49%

-0.39%

-8.77%

-9.18%

YTD

+0.26%

+17.96%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.23

SMA (50)

$36.54

SMA (200)

$42.18

Price vs SMA50

+4.15%

Price vs SMA200

-9.76%

ATR (14)

$1.07

Financials

Revenue

$240M

Net Income

$11M

Gross Margin

28.6%

Operating Margin

7.4%

Net Margin

4.7%

Return on Equity

16.1%

Return on Assets

6.5%

Current Ratio

2.12

Debt / Equity

0.30

Revenue Growth (YoY)

+18.0%

Latest reported annual period ending 2025-04-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	$2.09	2026-03-13
Q2 2026	$1.86	2025-12-12
Q1 2026	$1.04	2025-09-12
FY 2025	$3.83	2025-07-02
Q3 2026	$2.20	2026-03-13
Q2 2026	$1.75	2025-12-12

Full earnings history →

Healthcare peers

KEQU vs 14 sector peers (Healthcare), by market cap.

P/E vs peers

9.57 / 25.98 med

-63% discount

P/S vs peers

0.45 / 2.59 med

-82% discount

Net margin vs peers

4.7% / 0.0% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.